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Abstract
Introduction. The limited scientific knowledge on the relationship between exposure 
and health effects in relation to geothermal activity motivated an epidemiologic investi-
gation of Tuscan geothermal area. 
Aim. This study aims at describing mortality of populations living in Tuscan municipali-
ties in the period 2003-2012. 
Method. Sixteen municipalities were included in the study area: eight in the northern 
and eight in the southern area. Mortality data come from the Regional Mortality Reg-
istry of Tuscany. Fifty-four causes of death, considered of interest for population health 
status or consistent with “Project SENTIERI” criteria, are analyzed. 
Results. Results show a worse mortality profile in the southern area, especially in males, 
for whom excesses of all cancers and some causes of cancer emerge, while in the north-
ern area an excess of cerebrovascular diseases among females merits attention. Further 
and more appropriate studies are needed to clarify the etiology of some diseases and to 
better assess a potential cause-effect relationship.
INTRODUCTION
Geothermics studies the production and the transfer 
of heat that originates in the earth’s crust following the 
decay of radioactive isotopes [1, 2]. Volcanoes, geysers, 
fumaroles and hot springs are all natural visible mani-
festations of this thermal energy contained in the earth. 
Geothermal areas are characterized by geological con-
ditions that allow a vector (water in liquid or gas phase) 
to transport heat from a thermal source to the surface. 
Electricity production is the most important use of con-
ventional geothermal resources at high temperature 
(> 150 °C), as in the case of geothermal areas of Tusca-
ny. For the production of electric energy the geothermal 
fluid is extracted from deep wells and then re-injected 
through appropriate wells.
The environmental impact caused by the exploitation 
of geothermal energy has recently become subject of 
further investigations. Geothermal plants for energy 
production promote the transportation to the surface 
of fluids with emission in the atmosphere of vapors gas-
es and pollutants that can reach concentrations higher 
than those of natural emissions [3].
Emissions from geothermal plants in Tuscany con-
sist of steam and gases released through cooling towers 
and, once condensed, they are reinjected while sludge 
is disposed in landfills. Gas emissions in air are mostly 
composed of carbon dioxide (CO2) (85.4%), hydrogen 
sulfide (H2S) (1-2%) and methane (CH4) (0.4%) [3]. 
Nitrogen, hydrogen, ammonia, boric acid, radon, rare 
gases and volatile forms of trace elements such as mer-
cury, arsenic and antimony are emitted to a lesser ex-
tent [3]. In addition to pollutant emissions, geothermal 
exploitation may be accompanied by subsidence prob-
lems, landscape damages, and interference with natural 
seismicity, noise pollution for plant workers and resi-
dents in the proximity of the plants.
To date studies on populations residing in geothermal 
areas are still scarce: seven studies were conducted in 
Rotorua (New Zealand) [4-6, 10-13] and one in Ha-
waii [7]. Rotorua is located in the active volcanic area 
of Taupo, characterized by one of the largest communi-
ties in the world exposed to geothermal emissions. In 
the Seventies, monitoring surveys showed a quarter of 
the population exposed to H2S above 200 µg/m3, with 
peak concentrations above 1.500 µg/m3. It should be 
noticed that World Health Organization (WHO) now 
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indicates a guideline value for H2S of 150 µg/m3 (24-h 
average) [8] and tolerable concentrations for short-term 
and for medium-term exposure of 100 µg/m3 (on a pe-
riod of 1-14 days) and 20 µg/m3 (on a period of 90 days), 
respectively [9]. Bates et al. conducted five out of the 
seven studies led in Rotorua. Three ecological studies re-
vealed statistically significant excesses of respiratory sys-
tem diseases among Maori women [4], an elevated rate 
of nasal cancer (based on four cases) [5] and increasing 
trends with increasing exposure for neurological causes 
of respiratory and cardiovascular diseases among the 
entire population [6]. On the other hand two analytical 
studies reported no association between H2S exposure 
and asthma symptoms [11], lung function and Chronic 
Obstructive Pulmonary Diseases (COPD) [13].
With regard to studies in Rotorua not performed by 
Bates et al., a study revealed significant clusters of re-
spiratory disease cases, of asthma and of COPD [10], 
and an analytical study reported no association between 
H2S exposure and cognitive function [12].
The only study not conducted in Rotorua investigated 
two communities living in areas prone to H2S exposure, 
due to a geothermal power plant in Puna (Hawaii) and 
an industrial plant in Odessa (Texas). Odessa is charac-
terized by an annual average concentration of H2S in the 
range 3-40 µg/m3 and a daily maximum concentration of 
150-300 µg/m3 while Puna by low values of H2S (µg/m3), 
with occasional peaks. Authors observed greater risks 
for symptoms of central nervous system, for respiratory 
symptoms and for haematological disorders [7].
To date, these epidemiological studies on population 
exposed to geothermal emissions suggest a possible 
association between exposure to H2S and health out-
comes affecting the central nervous system and the re-
spiratory system. Designs of the studies actually carried 
out are not sufficient to highlight a causal relationship 
between exposure and effect.
In 2012, we carried out an ecological study aimed to 
describe, in the period 2000-2006, the health status of 
populations living in Tuscan municipalities where con-
cessions for exploitation of geothermal resources were 
granted [14]. The study is focused on the geothermal 
areas of Tuscany, between Pisa, Siena and Grosseto 
provinces. In these areas, geothermal resource has been 
exploited for a long time in order to produce electric en-
ergy and, to a smaller extent, in order to heat dwellings. 
Geothermal activities are present in central-southern 
Tuscany, the metalliferous hills and the Amiata massif, 
where two main areas are identified:
• the Amiata Mountain area (named hereafter “South-
ern Area”) consists of 8 municipalities (Abbadia San 
Salvatore, Arcidosso, Castel del Piano, Piancastag-
naio, Radicofani, Roccalbegna, San Casciano dei Ba-
gni, Santa Fiora). This area is rich in thermal springs 
used for healing purposes and recreation. The sulfur 
springs are accompanied by the issue of H2S in the at-
mosphere and, in the case of hot water, even mercury 
vapor [15]. Since the end of 1800 this area hosted 
a thriving mining of cinnabar (mercury sulfide-HgS), 
utilized for the production of metallic mercury. In 
this area there are still many decommissioned plants, 
evidence of past activity, whose decline began in the 
years 1960-1970. When the study began, in this area 
there were 5 plants with an installed total capacity of 
88 MWe;
• the traditional area (named hereafter “Northern 
Area”) consists of 8 municipalities (Castelnuovo Val 
di Cecina, Chiusdino, Montecatini Val di Cecina, 
Monteverdi Marittimo, Monterotondo Marittimo, 
Montieri, Pomarance, Radicondoli). In this area, 
where in XIX century the commercial exploitation of 
lagoons for production of boric acid started, thermal 
baths are few, but manifestations of endogenous gas 
rich in CO2 and H2S are widespread. Since then, the 
use of geothermal fluids has undergone a progressive 
increase. When the study began, in this area there 
were 27 plants with a total capacity of 764.5 MWe.
In these areas, both Regional Agency for the Envi-
ronmental Protection  of Tuscany (ARPAT) and Italian 
National Electricity Authority (ENEL) Green Power 
constantly monitor air quality, covering both the geo-
thermal area and the towns affected by the geothermal 
plant emissions. The historic performance of H2S con-
centrations in the air, as annual averages (µg/m³), re-
corded from 2010 to 2012 in geothermal areas of Tusca-
ny, shows a general improvement. The geothermal area 
of Amiata, in the Province of Grosseto, presents lower 
values, during 2010-2011-2012 (2.99-1.99-1.11 µg/m³, 
respectively) compared to other Tuscan geothermal ar-
eas (22.95-27.66-15.72 µg/m³) [16].
Objectives of the study
The present study was carried out in the same areas 
defined in the previous study [14], in order to describe 
mortality in the population residing in the geothermal 
areas of Tuscany in the period 2003-2012, and to gener-
ate hypotheses for promoting further etiological epide-
miological investigations.
MATERIALS AND METHODS
The population residing in the geothermal area in the 
period 2003-2012 was considered. The average resident 
population from 01-01-2003 to 12-31-2012 was 40 461 
subjects, 19 678 men and 20 784 women. The popula-
tion of the Southern Area accounted for 58.9% of the 
whole area.
Mortality causes. Data come from the Tuscan Regional 
Mortality Register and are classified according to the 
IX International Classification of Disease (ICD-IX). 
The group of causes and specific causes analyzed in this 
study are reported in Table 1.
Statistical methods. Statistical analysis was conducted 
by the following aggregated areas:
• Northern Area (named hereafter NoA);
• Southern Area (named hereafter SoA);
• Geothermal Area (Northern Area plus Southern 
Area, named hereafter GeA).
In order to calculate the expected events in the study 
areas, the mortality rates of both regional and sub-re-
gional population were used as reference figures. The 
sub-regional area included 98 municipalities having the 
geographical coordinates of the main town falling in a 
50 km radius from the edge of the study area. The ra-
dius of 50 km was chosen with the purpose of having 
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a large area with socio-economic and cultural charac-
teristics more similar to the study area than the whole 
region (the study area accounted for 7% of the sub-
regional area). Those towns with a population above 
50 000 inhabitants were excluded from the sub-regional 
reference area to avoid the inclusion of subpopulations 
with environmental and socio-economic characteristics 
dissimilar from the reference area. 
Standardized Mortality Ratios (SMRs) by age and 
Deprivation Index (DI) classes were calculated for to-
tal mortality and all causes of death for women, men, 
and both gender. The Confidence Interval (CI) was 
calculated using the Byar’s approximate method [17]. 
To adjust the SMRs by socio-economic status, the DI 
proposed by Caranci was used [18].
For causes of death with a number of observations 
less than 3, SMRs are not reported in Table 1.
RESULTS
In the GeA, 6441 deaths (3111 males and 3330 fe-
males) occurred in the period 2003-2012: 38% of which 
among the 14 200 residents in the NoA (1188 males 
and 1256 females) and 62% among the 23 814 residents 
in the SoA (1923 males and 2074 females). 
Table 1 shows DI-adjusted SMRs by area and gender 
for each cause or group of causes of death for the pe-
riod 2003-2012.
Hereafter only statistically significant results or inter-
esting results approaching but not reaching statistically 
significance will be discussed.
Considering all causes of death, the GeA shows an 
excess of mortality approaching but not reaching sta-
tistical significance only among males of + 3%. This 
excess is statistically significant in the SoA (+ 6%), par-
ticularly among males (+ 9%). Excesses in the SoA are 
significant both in the age classes 35-64 years and > 65 
years. Concerning neoplasms in general (ICD-IX: 140-
239), the SoA presents an excess of mortality of 10%, 
particularly among males (+ 16%). On the contrary, the 
NoA presents a number of deaths lower than expect-
ed (- 12%), particularly among males (- 14%). Among 
males within the GeA no statistically significant results 
for malignant diseases are observed but we highlight 
two interesting excesses approaching but not reaching 
statistically significance for malignant neoplasm of lip, 
oral cavity and pharynx and for liver. Among females, 
excesses of mortality for malignant neoplasms of ovary 
of + 38% and of the central nervous system of + 48%, 
and a statistically significant defect of mortality for ma-
lignant neoplasms of breast (- 23%) are observed. The 
NoA presents an excess of mortality among females of 
+ 64% for malignant neoplasm of ovary and a defect 
of mortality among males of - 28% for malignant neo-
plasm of trachea, bronchus and lung. In the SoA we 
observe results for both gender. Among males, we no-
tice excesses of mortality for malignant neoplasms of: 
i) stomach (+ 46%); ii) liver, gallbladder and bile ducts 
(+ 53%); iii) a defect of mortality for malignant neo-
plasm of lymphatic and hematopoietic tissue (- 31%) 
and iv) a not statistically significant excess for malig-
nant neoplasm of lip, oral cavity and pharynx (+ 65%). 
Among females only an excess of mortality of + 84% for 
malignant neoplasm of the central nervous system and 
an interesting but not statistically significant excess for 
malignant neoplasm of stomach (+ 29%) are observed. 
We also observe two results that approach but not reach 
statistically significance for Parkinson’s disease among 
males of the GeA and for senile and presenile organic 
psychotic conditions among females in the NoA.
Regarding diseases of the circulatory system (ICD-
IX: 390-459) only the SoA presents a statistically sig-
nificant result: a defect of mortality for both males and 
females of - 9% and - 7%, respectively. Within the group 
of cardiac diseases, in the areas we mainly observe de-
fects of mortality in the areas. In fact, both GeA and 
SoA present defects of mortality for ischemic heart dis-
ease among both gender. Specifically, the GeA presents 
this defect of - 14% and of - 19% among males and fe-
males respectively, and the SoA of - 21% and of - 24% 
among males and females, respectively. The only excess 
of mortality is reported for cerebrovascular disease in 
the NoA among females (+ 15%).
For the diseases of the respiratory system in general 
(ICD-IX: 460-519), we observe excesses of mortality 
only among males in all the three areas. In the GeA the 
excess is of + 34%, in the NoA of + 32% and in the SoA 
of + 35%. We also report a not statistically significant 
excess among females of the SoA. Among diseases of 
the respiratory system all the three areas show excess-
es for pneumoconiosis among males: GeA of + 225%, 
NoA of + 264% and SoA of + 198%. GeA presents ex-
cesses among males for bronchopneumopathy chronic 
obstructive (+ 19%) while the SoA shows statistically 
significant excesses only among females for acute respi-
ratory infections (+ 42%), specifically for pneumonia (+ 
37%) and excesses approaching but not reaching statis-
tical significance for the same diseases among males.
For the digestive system diseases (ICD-IX: 520-579) 
we report excesses of mortality among females of the 
GeA (+ 34%) and for both gender of the SoA (males + 
27%; females + 47%). Among digestive system diseases 
we observe excesses of mortality for chronic liver disease 
and cirrhosis among females in the GeA (+ 48%) and for 
both gender in the SoA (males + 61%; females + 69%).
The SoA shows excesses of mortality not statistically 
significant for both gender for congenital anomalies 
(males + 156%; females + 143%) and statistically sig-
nificant excesses for injury and poisoning among males 
(+ 34%).
We observe excesses of mortality for symptoms, signs, 
and ill-defined conditions (ICD-IX: 780-799) in the 
GeA among females (+ 62%) and in the SoA for both 
gender (males + 63%; females + 126%), while in the 
NoA a defect of mortality among females (- 36%) is 
reported.
It should be noticed that most of the previously com-
mented results are significant for the age class > 65 
years. Some results are significant for the age class 35-
64, such as:
• diseases of the digestive system among males in the 
SoA;
• chronic liver diseases and cirrhosis among females of 
the GeA and for both gender of the SoA;
• injury and poisoning among males in the SoA.
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Table 1
Standardized Mortality Ratios (SMRs) for each cause (or group of causes) of death, differentiated by area, gender and adjusted by 
deprivation index. Period 2003-2012
Disease ICD-IX 
Code
GEOTHERMAL AREA NORTHERN AREA SOUTHERN AREA
MALES FEMALES MALES FEMALES MALES FEMALES
OBS SMR  
(CI 95%)
OBS SMR  
(CI 95%)
OBS SMR  
(CI 95%)
OBS SMR  
(CI 95%)
OBS SMR  
(CI 95%)
OBS SMR  
(CI 95%)
All causes 0-999 3111 103 
(100-107)
3330 101 
(98-105)
1188 96 
(90-101)
1256 98 
(92-103)
1923 109 
(104-114)
2074 104 
(99-108)
Infectious and parasitic 
diseases
001-139 31 130 
(88-185)
25 88 
(57-130)
11 113 
(56-202)
10 90 
(43-166)
20 142 
(87-220)
15 86 
(48-143)
Tubercolosis 010-018 3 207 
(42-605)
< 3 < 3 < 3 < 3 0
Viral hepatitis 070 5 122 
(39-285)
4 81 
(22-208)
< 3 3 156 
(31-456)
4 164 
(44-420)
< 3
Neoplasms 140-239 1015 104 
(97-110)
712 97 
(90-105)
342 86 
(77-95)
258 91 
(80-103)
673 116 
(107-125)
454 102 
(92-111)
Malignant neoplasm 
of lip, oral cavity, and 
pharynx
140-149 25 145 
(94-214)
5 65 
(21-153)
8 115 
(50-228)
3 101 
(20-296)
17 165 
(96-263)
< 3
Malignant neoplasm 
of esophagus
150 13 95 
(50-162)
6 132 
(48-287)
4 72 
(19-185)
< 3 9 110 
(50-209)
5 179 
(58-418)
Malignant neoplasm 
of stomach
151 94 118 
(95-144)
68 117 
(91-148)
25 77 
(50-113)
22 97 
(61-147)
69 146 
(114-185)
46 129 
(95-173)
Malignant neoplasm 
of colon and rectum
153-154 135 105 
(88-125)
109 94 
(78-114)
43 82 
(60-111)
45 100 
(73-134)
92 121 
(98-149)
64 91 
(70-116)
Malignant neoplasm 
of liver, gallbladder 
and bile ducts
155-156 76 124 
(98-155)
53 113 
(85-148)
20 81 
(49-124)
21 115 
(71-176)
56 153 
(116-199)
32 112 
(76-157)
Malignant neoplasm 
of pancreas
157 46 99 
(72-132)
54 104 
(78-136)
18 96 
(57-151)
17 84 
(49-135)
28 101 
(67-147)
37 117 
(82-161)
Malignant neoplasm 
of larynx
161 21 137 
(85-210)
0 10 162 
(77-298)
0 11 121 
(60-216)
0
Malignant neoplasm 
of trachea, bronchus, 
and lung
162 234 98 
(86-112)
55 82 
(62-107)
69 72 
(56-91)
16 62 
(35-100)
165 117 
(100-136)
39 95 
(68-130)
Malignant neoplasm 
of pleura
163 9 134 
(61-254)
< 3 6 220 
(80-479)
< 3 3 75 
(15-219)
0
Malignant neoplasm 
of connective and 
other sort of tissue
171 < 3 < 3 0 < 3 < 3 5 260 
(84-608)
Malignant neoplasm 
of skin
172 9 82 
(38-156)
7 89 
(36-183)
4 91 
(25-234)
3 99 
(20-288)
5 76 
(25-178)
4 82 
(22-211)
Malignant neoplasm 
of breast
174-175 0 76 77 
(61-97)
0 30 79 
(53-112)
0 46 76 
(56-102)
Malignant neoplasm 
of uterus
179-180, 
182
0 23 81 
(52-122)
0 11 101 
(50-180)
0 12 69 
(36-121)
Malignant neoplasm 
of ovary and other 
uterine adnexa
183 0 48 138 
(102-183)
0 22 164 
(103-248)
0 26 122 
(80-179)
Malignant neoplasm 
of prostate
185 90 105 
(85-129)
0 30 85 
(57-121)
0 60 120 
(91-154)
0
Malignant neoplasm 
of bladder
188 54 105 
(79-136)
15 108 
(60-178)
20 94 
(58-146)
6 110 
(40-240)
34 112 
(77-156)
9 107 
(49-202)
Malignant neoplasm 
of kidney and other 
and unspecified 
urinary organs
189 27 101 
(67-147)
12 69 
(35-120)
14 130 
(71-217)
< 3 13 82 
(44-140)
10 94 
(45-172)
Malignant neoplasm 
of the central 
nervous system
191-192, 
225, 
239.6
29 104 
(69-149)
38 148 
(104-203)
10 89 
(43-164)
9 91 
(41-172)
19 114 
(68-178)
29 184 
(123-264)
Malignant neoplasm 
of lymphatic and 
hematopoietic tissue
200-208 62 81 
(62-104)
64 94 
(73-121)
31 100 
(68-142)
27 103 
(68-149)
31 69 
(47-97)
37 89 
(63-123)
Non Hodgkin 
lymphoma
200-202 19 78 
(47-122)
18 83 
(49-131)
10 101 
(49-186)
8 95 
(41-187)
9 62 
(28-118)
10 76 
(36-139)
Hodgkin’s disease 201 < 3 < 3 < 3 < 3 0 0
Continues
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Table 1
Continues
Disease ICD-IX 
Code
GEOTHERMAL AREA NORTHERN AREA SOUTHERN AREA
MALES FEMALES MALES FEMALES MALES FEMALES
OBS SMR  
(CI 95%)
OBS SMR  
(CI 95%)
OBS SMR  
(CI 95%)
OBS SMR  
(CI 95%)
OBS SMR  
(CI 95%)
OBS SMR  
(CI 95%)
Multiple myeloma 203 19 105 
(63-163)
16 94 
(53-152)
8 108 
(46-212)
4 60 
(16-154)
11 103 
(51-183)
12 115 
(59-200)
Leukemia 204-208 23 73 
(46-110)
28 103 
(69-149)
12 94 
(48-164)
13 123 
(66-211)
11 59 
(29-106)
15 91 
(51-149)
Diabetes mellitus 250 76 100 
(79-125)
102 93 
(76-113)
28 89 
(59-129)
35 81 
(57-113)
48 107 
(79-142)
67 101 
(78-128)
Senile and presenile 
organic psychotic 
conditions
290 22 66 
(42-100)
90 108 
(87-132)
8 57 
(25-112)
44 134 
(97-179)
14 73 
(40-122)
46 91 
(66-121)
Diseases of the nervous 
system and sense 
organs
320-389 96 96 
(78-117)
134 94 
(79-112)
44 107 
(78-143)
54 97 
(73-126)
52 88 
(66-116)
80 93 
(73-115)
Parkinson’s disease 332 37 135 
(95-186)
26 98 
(64-144)
14 123 
(67-207)
10 96 
(46-177)
23 144 
(91-216)
16 99 
(57-162)
Motor neuron 
disease
335.2 7 96 
(39-198)
8 107 
(46-211)
< 3 4 139 
(37-356)
6 138 
(50-299)
4 87 
(23-224)
Multiple sclerosis 340 < 3 0 < 3 0 0 0
Epilepsy 345 < 3 < 3 0 < 3 < 3 < 3
Diseases of the 
circulatory system
390-459 1067 95 
(89-101)
1471 97 
(92-102)
467 100 
(91-110)
611 102 
(94-110)
600 91 
(84-99)
860 93 
(87-99)
Hypertensive disease 401-405 51 92 
(69-121)
114 103 
(85-124)
22 96 
(60-145)
52 120 
(89-157)
29 90 
(60-129)
62 92 
(71-118)
Acute myocardial 
infarction of 
anterolateral wall
410 141 86 
(72-101)
148 99 
(84-117)
60 89 
(68-115)
64 109 
(84-140)
81 83 
(66-104)
84 93 
(74-115)
Ischemic heart 
disease
410-414 338 86 
(77-96)
325 81 
(73-91)
157 97 
(83-114)
141 90 
(76-106)
181 79 
(68-91)
184 76 
(65-88)
Cerebrovascular 
disease
430-438 313 99 
(88-110)
501 104 
(95-113)
143 109 
(91-128)
219 115 
(101-132)
170 92 
(79-107)
282 96 
(85-108)
Diseases of the 
respiratory system
460-519 348 134 
(120-149)
199 110 
(95-127)
143 132 
(111-155)
72 102 
(79-128)
205 135 
(117-155)
127 116 
(97-138)
Acute respiratory 
infections
460-466, 
480-487
63 110 
(84-141)
74 121 
(95-151)
19 79 
(48-124)
21 87 
(54-133)
44 132 
(96-177)
53 142 
(107-186)
Pneumonia 480-486 60 113 
(86-146)
61 115 
(88-148)
19 86 
(52-134)
17 82 
(48-131)
41 133 
(95-180)
44 137 
(100-184)
Bronchopneu-
mopathy chronic 
obstructive
491-492, 
494-496
153 119 
(101-139)
76 108 
(85-135)
66 123 
(95-156)
33 120 
(82-168)
87 116 
(93-143)
43 101 
(73-136)
Asthma 493 2 109 
(12-395)
8 167 
(72-330)
< 3 3 161 
(32-470)
< 3 5 172 
(55-400)
Pneumoconiosis 500-505 79 325 
(258-406)
0 37 364 
(256-502)
0 42 298 
(215-402)
0
(0-4745)
Diseases of the 
digestive system
520-579 123 110 
(91-131)
171 134 
(114-155)
39 85 
(61-117)
57 114 
(86-148)
84 127 
(101-157)
114 147 
(121-176)
Chronic liver disease 
and cirrhosis
571 44 125 
(91-168)
43 148 
(107-199)
10 71 
(34-131)
13 115 
(61-197)
34 161 
(111-224)
30 169 
(114-241)
Diseases of the 
genitourinary system
580-629 55 94 
(70-122)
66 105 
(81-133)
24 98 
(63-146)
32 130 
(89-183)
31 90 
(61-128)
34 89 
(61-124)
Nephritis 581-583 0 < 3 0 < 3 0 0
Acute and chronic 
renal failure
584-585 53 112 
(84-147)
55 105 
(79-137)
22 112 
(70-169)
24 117 
(75-175)
31 112 
(76-159)
31 98 
(66-139)
Congenital anomalies 740-759 7 180 
(72-370)
8 199 
(86-392)
< 3 < 3 6 256 
(93-556)
6 243 
(89-529)
Symptoms, signs, and 
ill-defined conditions
780-799 49 122 
(90-161)
155 162 
(137-189)
11 65 
(32-116)
24 64 
(41-95)
38 163 
(115-224)
131 226 
(189-268)
Injury and poisoning 800-999 157 116 
(99-136)
96 104 
(85-128)
49 90 
(67-119)
31 86 
(59-123)
108 134 
(110-162)
65 116 
(90-148)
Legend: OBS: observed; SMR: Standardized Mortality Ratio; CI 95%: Confidence Interval for 95th Percentile.
Note: Statistically significant excesses of mortality are highlighted in orange. Statistically significant defects of mortality are highlighted in green. Results 
approaching but not reaching statistical significance are highlighted in blue.
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DISCUSSION
Between 2003 and 2012, an excess of mortality for all 
causes approaching but not reaching statistical signifi-
cance is observed among males in the GeA of Tuscany, 
confirming previous results. In this study mortality in 
excess among males is relevant for diseases of the re-
spiratory system, in particular for pneumoconiosis, as 
in the preceding study, and for bronchopneumopathy 
chronic obstructive. Compared to the previous study 
[14], excesses of mortality for infectious and parasitic 
diseases, tuberculosis, diseases of the nervous system 
among males of GeA are not confirmed (Table 2). In 
fact, these causes have a multifactorial etiology. For 
instance, pneumoconiosis is associated with occupa-
tional exposures [19-27], and is one of the most im-
portant risk factors for pulmonary tuberculosis [28-
32]. Usually, going forward in time, mortality due to 
work activities (mining, in this case) decreases. In this 
framework, to explain the fact that past results are not 
confirmed, the gradual extinction since the 80s of the 
cohorts of workers employed in mining activities seems 
to be likely. Regarding females, excesses of mortality 
for cancer of the ovary and other uterine adnexa, of the 
central nervous system and digestive system diseases, 
and a lower mortality for breast cancer are observed. 
Furthermore, compared to the previous study, excesses 
of mortality for liver diseases and cirrhosis and lower 
mortality for circulatory system diseases and ischemic 
heart diseases are confirmed (Table 2). High mortality 
from cirrhosis focuses attention towards the exposure 
to hepatitis B and C, or long-term alcohol abuse, rather 
than towards factors of environmental pollution [33]. 
Lower mortality for ischemic heart disease observed in 
both gender is not easy to interpret due to many recog-
nized risk factors [34].
A clear geographical heterogeneity appears, with a 
mortality profile worst in the south than in the north, as 
previously observed.
In fact, in the NoA, mortality among males from can-
cers of all sites and in particular for lung cancer is lower 
than expected, and only mortality for diseases of the 
respiratory system, particularly for pneumoconiosis, is 
reported in excess. Among females, significant excesses 
for ovarian cancer and cerebrovascular diseases are re-
ported, confirming previous results (Table 2). Several risk 
factors, including exposure to asbestos, are recognized 
associated with ovarian cancer [34, 35]. For cerebrovas-
cular diseases there is sufficient evidence for environ-
mental factors, smoking habit and alcohol consump-
tion [36]. Our results are in agreement with literature 
[6, 10] only with regard to respiratory system diseases 
among men, not among women. At the same time, we 
do not detect excesses of neurological causes observed 
in other studies [6, 7]. In summary, in the NoA, where 
the majority of geothermal power plants are located, 
few excesses of mortality emerge. Some of these are 
reasonably attributable to occupational factors, as for 
pneumoconiosis among males. Other excesses are in-
stead potentially associated with multiple risk factors, as 
for cerebrovascular diseases among females. 
Among males in the SoA, total mortality, mortality for 
all cancers, particularly liver cancer, exceeds the expec-
tation confirming previous results. This study identifies 
an excess of mortality for stomach cancer not observed 
before and an excess approaching but not reaching sta-
tistical significance for lung cancer confirming previous 
findings (Table 2).
In this regard it is noteworthy that a high incidence 
of stomach cancer has been reported for a long time 
in several mountain areas of Tuscany. Although major 
epidemiological evidence of the causes of stomach can-
cer is attributable to cigarettes smoking, socioeconomic 
factors, diet, exposure to Helicobacter pylori, and ge-
netic factors [36], the role of environmental factors, in 
particular exposure to chemical contaminants, cannot 
be excluded [37]. The occurrence of liver cancer is in-
stead related to chronic damage of the liver and its de-
terminants, including alcohol abuse and infections from 
hepatitis B and C viruses [38-41]. Excesses of mortal-
ity among males for diseases of the respiratory system, 
particularly for pneumoconiosis are observed as in the 
previous study. This study reveals excesses of mortality 
for the digestive system, particularly for cirrhosis and 
defects for cancer of lymphatic and hematopoietic tis-
sue and for circulatory system diseases, in particular 
for ischemic heart disease not observed before (Table 
2). Since the significant excess of mortality for diseases 
of the respiratory system in the SoA is observed only 
among males, past occupational exposures and tobacco 
smoking habit are the more reasonably plausible causes.
Among females of the SoA excesses of mortality for 
cancer of the central nervous system, for pneumonia 
and cirrhosis are observed and excesses of mortality 
for acute respiratory infections, particularly pneumoco-
niosis, and for digestive system diseases are confirmed 
(Table 2).
Significant defect of mortality for circulatory system 
diseases, particularly for ischemic heart disease, is also 
observed among females of the SoA, as it occurs among 
males.
In an area with emissions from geothermal plants, 
mortality excesses of diseases with a short incubation 
period, as for acute respiratory diseases, for which it is 
difficult to assign a role of occupational exposures, a 
targeted strategy of environmental monitoring and epi-
demiological surveillance seems appropriate.
It should be noted that among acute respiratory dis-
eases, pneumonia seems to be the most common, in 
particular in the age class ≥ 65 years. This is often of 
questionable reliability in death certificates.
The mortality excess for digestive system diseases is 
largely attributable to liver cirrhosis in the SoA. It is 
complex to interpret a lower mortality from cerebrovas-
cular diseases only among females.
In summary, this study shows a worst mortality profile 
in the SoA, especially in males, for whom excesses for 
all cancers and some causes of cancer emerge, while in 
the NoA an excess for cerebrovascular diseases among 
females is noteworthy.
 Finally, although the role of ecological (or geographi-
cal) studies in epidemiology and their consequences in 
public health have been addressed in several scientific 
papers [42-45], it should be reminded that this kind of 
study, adopted in this work, is not suitable for produc-
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Table 2 
Standardized Mortality Ratios (SMRs) for each cause (or group of causes) of death, differentiated by area, gender, period of analysis 
(2000-2006; 2003-2013) and adjusted by deprivation index
Disease GEOTHERMAL AREA NORTHERN AREA SOUTHERN AREA
MALES
SMR (CI 95%)
FEMALES
SMR (CI 95%)
MALES
SMR (CI 95%)
FEMALES
SMR (CI 95%)
MALES
SMR (CI 95%)
FEMALES
SMR (CI 95%)
2000-
2006
2003-
2012
2000-
2006
2003-
2012
2000-
2006
2003-
2012
2000-
2006
2003-
2012
2000-
2006
2003-
2012
2000-
2006
2003-
2012
All causes 108 
(103-112)
103 
(100-107)
115 
(109-211)
109 
(104-114)
Infectious and 
parasitic diseases
245 
(159-362)
130 
(88-185)
250 
(125-447)
113 
(56-202)
Tubercolosis 421 
(182-830)
207 
(42-605)
539 
(216-1109)
*
Neoplasms 87 
(76-98)
86 
(77-95)
121 
(110-131)
116 
(107-125)
Malignant 
neoplasm of 
stomach
122 
(91-159)
146 
(114-185)
Malignant 
neoplasm of liver, 
gallbladder and 
bile ducts
171 
(122-234)
153 
(116-199)
Malignant 
neoplasm of 
trachea, bronchus, 
and lung
78 
(59-101)
72 
(56-91)
121 
(101-145)
117 
(100-136)
Malignant 
neoplasm of breast
80 
(60-104)
77 
(61-97)
Malignant 
neoplasm of ovary 
and other uterine 
adnexa
126 
(84-181)
138 
(102-183)
172 
(100-275)
164 
(103-248)
Malignant 
neoplasm of the 
central nervous 
system
108 
(68-164)
148 
(104-203)
109 
(60-184)
184 
(123-264)
Malignant 
neoplasm of 
lymphatic and 
hematopoietic 
tissue
101 
(68-144)
69 
(47-97)
Diseases of the 
nervous system and 
sense organs
130 
(101-163)
96 
(78-117)
Diseases of the 
circulatory system
96 
(91-102)
97 
(92-102)
103 
(94-113)
91 
(84-99)
94 
(87-102)
93 
(87-99)
Ischemic heart 
disease
85 
(74-97)
81 
(73-91)
101 
(86-118)
79 
(68-91)
87 
(73-104)
76 
(65-88)
Cerebrovascular 
disease
122 
(104-142)
115 
(101-132)
Diseases of the 
respiratory system
129 
(112-147)
134 
(120-149)
124 
(99-152)
132 
(111-155)
132 
(110-157)
135 
(117-155)
Acute respiratory 
infections
142 
(102-193)
142 
(107-186)
Pneumonia 120 
(81-173)
137 
(100-184)
Bronchopneu-
mopathy chronic 
obstructive
119 
(101-139)
Pneumoconiosis 372 
(277-489)
325 
(258-406)
351 
(214-542)
364 
(256-502)
388 
(263-550)
298 
(215-402)
Diseases of the 
digestive system
117 
(96-142)
134 
(114-155)
125 
(95-162)
127 
(101-157)
130 
(102-164)
147 
(121-176)
Chronic liver 
disease and 
cirrhosis
143 
(100-199)
148 
(107-199)
151 
(99-219)
161 
(111-224)
153 
(97-230)
169 
(114-241)
Symptoms, signs, and 
ill-defined conditions
147 
(113-187)
162 
(137-189)
61 
(29-111)
64 
(41-95)
190 
(119-287)
163 
(115-224)
197 
(148-255)
226 
(189-268)
Injury and poisoning 119 
(94-149)
134 
(110-162)
134 
(101-173)
116 
(90-148)
Legend: SMR: Standardized Mortality Ratio; CI: Confidence Interval. *SMR is not reported because the number of observations is less than 3.
Note: Statistically significant excesses of mortality are highlighted in orange. Statistically significant defects of mortality are highlighted in green. Results 
approaching but not reaching statistical significance are highlighted in blue.
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ing evidence on the cause-effect relationship. The major 
limitation of this design is the assumption of the resi-
dence at municipal level as a valid measure of exposure 
to both environmental and socio-economic factors. In 
fact, using aggregated health data can lead to results af-
fected by ecological fallacy [44, 46, 47]. Despite these 
limitations, well conducted ecological studies can show 
a satisfying scientific standard, also requiring a care-
ful integrated reading of their results over time and 
space and specific for each disease [48, 49]. Further-
more, such results can be integrated with studies on 
the strength of environment-health associations, using 
individual-level data, able to provide a precise spatio-
temporal characterization [50-52]. On the other hand, 
the study with macro-aggregated data (e.g. municipality 
level) is well recognized to be a useful first step to pro-
ceed towards studies with more advanced design for the 
understanding of the causal relationship [51, 53-56].
CONCLUSIONS
Taking into account limitations of studies with de-
scriptive epidemiological design, solely based on ag-
gregated environmental and health data, analyses per-
formed in this study show an epidemiological picture of 
the GeA similar to the one of adjacent not geothermal 
municipalities. However, there is no lack of critical el-
ements related to certain levels of environmental pol-
lution and to mortality excesses observed for a limited 
number of diseases, most evident in the SoA than in the 
NoA. Overall results, most critical for males, suggest 
that the major determinants of weaknesses observed in 
health profile are to be found mainly in occupations as-
sociated with productive activities of the past, without 
excluding recent exposures related to individual life-
styles, environmental agents or other factors not cur-
rently known. To clarify the etiology of acute respiratory 
diseases, in excess among women of the SoA, and cere-
brovascular diseases, in excess among women of the 
NoA, analytical studies seem to be appropriate.
Although the study design does not allow us any 
speculation about the cause-effect relationship, the 
observed mortality excesses in areas with documented 
presence of pollution and with high concern of local 
communities have strengthened directions for environ-
mental improvement and monitoring, and have sug-
gested priority settings for further environmental epi-
demiology insights to the regional and local authorities. 
A program including targeted etiological studies and 
human biomonitoring surveys is under development by 
the Regional government of Tuscany [57].
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